Your browser doesn't support javascript.
loading
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
Klepsch, Victoria; Hermann-Kleiter, Natascha; Do-Dinh, Patricia; Jakic, Bojana; Offermann, Anne; Efremova, Mirjana; Sopper, Sieghart; Rieder, Dietmar; Krogsdam, Anne; Gamerith, Gabriele; Perner, Sven; Tzankov, Alexandar; Trajanoski, Zlatko; Wolf, Dominik; Baier, Gottfried.
Afiliação
  • Klepsch V; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.
  • Hermann-Kleiter N; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.
  • Do-Dinh P; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.
  • Jakic B; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.
  • Offermann A; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany.
  • Efremova M; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.
  • Sopper S; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.
  • Rieder D; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.
  • Krogsdam A; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.
  • Gamerith G; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.
  • Perner S; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany.
  • Tzankov A; Department of Pathology, University of Basel, University Hospital Basel, 4031, Basel, Switzerland.
  • Trajanoski Z; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.
  • Wolf D; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.
  • Baier G; Medical Clinic III, Oncology, Hematology & Rheumatology, University Clinic Bonn, 53127, Bonn, Germany.
Nat Commun ; 9(1): 1538, 2018 04 18.
Article em En | MEDLINE | ID: mdl-29670099
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Esteroides / Fatores de Transcrição COUP / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Esteroides / Fatores de Transcrição COUP / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article